RxDoctor Payments Data

Amber Holden, PA

Physician Assistant · Temecula, CANPI 1033533666

Payments from drug & device makers

$1,081in general payments, 2019–2025

Across 46 payments — averaging $23.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$175
  • Novo Nordisk$119
  • Baxter Healthcare$109
  • AbbVie$107
  • AstraZeneca$64
  • Lilly USA, LLC$59
  • plus $448 from 16 others

What the payments were for

  • Food & beverage$97290%
  • Other$10910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,081 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$35,013
Medicare patients
209
Services billed
2,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$33,016
EliquisApixaban26$19,482
JanuviaSitagliptin Phosphate18$19,354
XareltoRivaroxaban13$19,109
RybelsusSemaglutide14$13,638
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen119$2,061
Levothyroxine Sodium133$1,703
Ondansetron OdtOndansetron18$1,507
Atorvastatin Calcium140$1,318
Albuterol Sulfate HfaAlbuterol Sulfate55$1,256
Venlafaxine Hcl ErVenlafaxine Hcl19$1,144
Metoprolol Succinate60$1,100
Losartan Potassium94$938
Lisinopril106$653
Omeprazole65$651

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$119$46,65349 claims
PfizerEliquis$33$19,48226 claims
AbbVieSynthroid$107$34821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Temecula

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →